<?xml version="1.0" encoding="UTF-8"?>
<p id="Par31">Seventy patients were selected from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate (BRAGGSS), previously described [
 <xref ref-type="bibr" rid="CR7">7</xref>], from contributing UK centres. Inclusion criteria specified that participants provided informed written consent, were Caucasian, were over 18â€‰years of age, and fulfilled the 2010 American College of Rheumatology (ACR)/European League Against Rheumatism (EULAR) criteria for RA [
 <xref ref-type="bibr" rid="CR13">13</xref>].
</p>
